Ambu A/S (CPH: AMBU.B)
Denmark
· Delayed Price · Currency is DKK 127.95
-25.10 (-16.40%)
Aug 30, 2024, 4:59 PM CET
Ambu A/S Revenue
Ambu A/S had revenue of 1.38B DKK in the quarter ending June 30, 2024, with 15.73% growth. This brings the company's revenue in the last twelve months to 5.26B, up 12.48% year-over-year. In the fiscal year ending September 30, 2023, Ambu A/S had annual revenue of 4.78B with 7.45% growth.
Revenue (ttm)
5.26B
Revenue Growth
+12.48%
P/S Ratio
6.47
Revenue / Employee
1.07M
Employees
4,616
Market Cap
34.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 4.78B | 331.00M | 7.45% |
| Sep 30, 2022 | 4.44B | 431.00M | 10.74% |
| Sep 30, 2021 | 4.01B | 446.00M | 12.50% |
| Sep 30, 2020 | 3.57B | 747.00M | 26.49% |
| Sep 30, 2019 | 2.82B | 214.00M | 8.21% |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
| Sep 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk A/S | 258.00B |
| Coloplast A/S | 26.30B |
| Genmab A/S | 19.02B |
| Demant A/S | 22.84B |
| Zealand Pharma A/S | 367.97M |
| H. Lundbeck A/S | 20.67B |
| H. Lundbeck A/S | 20.67B |
| ALK-Abelló A/S | 5.18B |
Ambu A/S News
- 10 months ago - ANNUAL REPORT 2022/23 (EARNINGS RELEASE) - GlobeNewsWire
- 1 year ago - Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities - GlobeNewsWire